Target intelligence / Profile preview

Brain expressed X-linked protein 1 (BEX1)

Target
BEX1
Molecular classification
Other (intrinsically disordered protein), Transcriptional co-regulator, Signaling adaptor molecule
01

Overview

Brain expressed X-linked protein 1 (BEX1) is an intrinsically disordered protein encoded by the BEX1 gene located on the X chromosome and primarily expressed in the brain, as well as testis, pancreas, and other tissues[1][3]. BEX1 functions as a signaling adaptor and transcriptional co-regulator, enabling binding to transcription factor complexes and facilitating positive regulation by RNA polymerase II[1][5]. It plays key roles in cell cycle progression, neuronal differentiation—in particular, acting as a modulator of neurotrophic signaling through p75 neurotrophin receptor (p75NTR/NGFR)—and mRNA stabilization as part of ribonucleoprotein complexes[2][3][5]. BEX1 is involved in tissue regeneration, neural repair (for example, upregulation after nerve injury to promote axon regeneration), and cellular differentiation, with context-dependent effects on proliferation or differentiation[1][3]. Aberrant expression or function of BEX1 has been implicated in several diseases, particularly in the context of cancer progression and as a novel factor induced in cardiac pathology, where it promotes inflammatory gene expression through direct mRNA interaction in cardiomyocytes[2][5]. Molecularly, it interacts with numerous RNA processing and transport proteins, including DDX3x, EPRS, and MAP4, but has no known enzyme activity or traditional receptor function[2]. At present, neither drugs targeting BEX1 nor validated uses as a biomarker for patient stratification or therapy monitoring have been reported.

Other names
BEX1Brain-expressed X-linked 1Protein BEX1Brain-expressed X-linked protein 1Ovarian granulosa cell 13.0 kDa protein hGR74HBEX2HGR74-hBEX2protein BEX1
02

Biological functions

Transcription regulation (positive regulation by RNA polymerase II)Signal transduction (p75NTR/NGFR signaling)Cell cycle progressionNeuronal differentiation (inhibition and modulation)mRNA processing and stabilization
03

Disease associations

CancerHeart failure/cardiomyopathyAcute myeloid leukemia (with MLL rearrangement)Neurodevelopmental disordersMicrophthalmia

Beyond the preview

Go deeper on Brain expressed X-linked protein 1 (BEX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain expressed X-linked protein 1 (BEX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call